These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7029820)

  • 21. Local immunosuppressive therapy with monoclonal anti-T-cell antibody on renal allograft survival in the rat. II. Phenotypic and functional assessment of spleen cells.
    Yoshimura N; Lee CJ; Shiho O; Kita M; Imanishi J; Oka T
    Transplant Proc; 1995 Feb; 27(1):390-1. PubMed ID: 7879033
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibodies to endothelial antigens in eluates of 88 human kidneys: correlation with graft survival and presence of T- and B-cell antibodies.
    Baldwin WM; Soulillou JP; Claas FH; Peyrat MA; van Es LA; van Rood JJ
    Transplant Proc; 1981 Sep; 13(3):1547-50. PubMed ID: 7029812
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor-specific flow cytometric cross-match after kidney transplantation.
    Puig N; Pallardó LM; Villalba JV; Sánchez J; Crespo J; Rodriguez R; Montoro JA
    Transplant Proc; 1995 Aug; 27(4):2369-70. PubMed ID: 7652842
    [No Abstract]   [Full Text] [Related]  

  • 25. New insights into therapy with monoclonal antibodies in allograft transplantation.
    Schena FP
    Nephrol Dial Transplant; 1997; 12 Suppl 1():55-8. PubMed ID: 9075230
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy.
    Orosz CG; Bergese SD; Huang EH; Vanbuskirk AM
    Transplant Proc; 1995 Feb; 27(1):387-8. PubMed ID: 7533414
    [No Abstract]   [Full Text] [Related]  

  • 27. In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.
    Blazar BR; Taylor PA; Vallera DA
    J Immunol; 1994 Apr; 152(7):3665-74. PubMed ID: 8144942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substantial peripheral T-cell depletion before grafting is beneficial in islet transplantation.
    Brons IG; Davies HS; Watson CJ; Cobbold SP; Waldmann H; Calne RY
    Transplant Proc; 1995 Dec; 27(6):3181. PubMed ID: 8539899
    [No Abstract]   [Full Text] [Related]  

  • 30. CD4 monoclonal antibodies in the preclinical dog renal allograft model.
    Watson CJ; Davies HS; Metcalfe SM; Cobbold SP; Rebello PR; Collier DS; Waldmann H; Calne RY
    Transplant Proc; 1993 Feb; 25(1 Pt 1):804-6. PubMed ID: 8438491
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of immunosuppressive agents on T-cell subsets, as evaluated by use of monoclonal anti-T-cell antibodies.
    Chatenoud L; Kreis H; Jungers P; Bach JF
    Transplant Proc; 1981 Sep; 13(3):1651-6. PubMed ID: 7029828
    [No Abstract]   [Full Text] [Related]  

  • 32. Daily monitoring of T cell subpopulations in renal allograft recipients: high-resolution measurement of T cell kinetics and their relevance to clinical course.
    Mohanakumar T; Ellis TM; Reinitz ER; Page SO; Mendez-Picon G; Goldman MH; Lower R; Lee HM
    Transplant Proc; 1984 Dec; 16(6):1490-1. PubMed ID: 6390851
    [No Abstract]   [Full Text] [Related]  

  • 33. Rituximab for humoral rejection after kidney transplantation: an update.
    Rostaing L; Guilbeau-Frugier C; Kamar N
    Transplantation; 2009 Apr; 87(8):1261. PubMed ID: 19384176
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of rhesus monkey allograft recipients with a combination of anti-T-cell monoclonal antibodies.
    Rebellato L; Gross U; Carver M; Cunningham P; Riley R; Ross W; Knowles R; Thomas J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):598-9. PubMed ID: 8094911
    [No Abstract]   [Full Text] [Related]  

  • 35. Preexisting antibodies: the clinical relevance of auto-B-lymphocyte antibody and positive B-cell crossmatch.
    Mongkolsuk T; Chiewsilp P; Sujirachato K; Sumethkul V; Jirasiritham S; Chalermsanyakorn P; Danviriyasup K
    Transplant Proc; 1996 Jun; 28(3):1215-6. PubMed ID: 8658631
    [No Abstract]   [Full Text] [Related]  

  • 36. Sequential study of immune mechanisms involved in graft acceptance in kidney transplantation.
    Mestre M; Bas J; Massip E; Valls A; Castelao AM; Grinyó JM; Alsina J; Buendia E
    Transplant Proc; 1995 Aug; 27(4):2371-3. PubMed ID: 7652843
    [No Abstract]   [Full Text] [Related]  

  • 37. Selective elimination of alpha/beta T cells as a model for peripheral T-cell tolerance.
    Dufter C; Terness P; Post S; Thies J; Otto G; Opelz G
    Transplant Proc; 1994 Dec; 26(6):3233-4. PubMed ID: 7998127
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of splenectomy on T cell subsets of peripheral blood lymphocytes in portal hypertension].
    Takeda A; Fujimoto Y; Yui S; Sakaguchi S; Kato N
    Nihon Geka Gakkai Zasshi; 1985 Apr; 86(4):507. PubMed ID: 3873597
    [No Abstract]   [Full Text] [Related]  

  • 39. T-cell flow-cytometry crossmatch and long-term renal graft survival.
    Rebibou JM; Bittencourt MC; Saint-Hillier Y; Chabod J; Dupont I; Bittard H; Chalopin JM; Hervé P; Tiberghien P
    Clin Transplant; 2004 Oct; 18(5):558-63. PubMed ID: 15344960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
    Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
    Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.